Associate Professor Fatima Valdes Mora is a cancer researcher with more than 15 years of experience, possessing a strong multidisciplinary profile in cancer epigenetics, cancer immuno-oncology, and bioinformatics.
Valdes Mora completed her PhD in December 2008 at the Universidad Autónoma de Madrid. She undertook postdoctoral training from 2009 to 2013 in Professor Susan Clark’s lab at the Garvan Institute in Sydney, Australia, focusing on epigenetics in adult cancer. In 2014, she was promoted to Group Leader, a semi-independent position at the Garvan Institute, where she concentrated her research on the epigenetics of breast and prostate cancer.
In 2020, Valdes Mora joined the Children’s Cancer Institute (CCI) as Group Leader of the Cancer Epigenetic Biology and Therapeutics Group, expanding her research into paediatric cancer epigenetics. In 2024, she assumed additional leadership roles within CCI and the University of New South Wales (UNSW), including Head of the Therapeutic Discovery Theme and Postgraduate Coordinator for the Childhood Cancer PhD program.